Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384813 · ClinicalTrials.gov registry record · Phase 2
Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma
A Phase 2 study of Asthma, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
- 2
- Study locations
NCT00384813: Completed Phase 2 study of Asthma, sponsored by Emory University.
NCT00384813 is a Phase 2 study of Asthma that has completed, run by Emory University. The registered enrollment target is 43 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00384813, a Phase 2 study of Asthma, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Stress and anxiety can negatively affect children with asthma. Reducing the stress of asthmatic children and their families may lead to improved asthma care and fewer asthma symptoms in the children. The purpose of this study is to develop and evaluate a family-focused asthma education program aimed at reducing stress levels and improving asthma care for urban children with asthma.
Primary Outcome
Family Asthma Management System Scale is semi-structured clinical interview that includes open-ended questions assessing family management of pediatric asthma. The interview is recorded and rated using a standard manual on seven core subscales and two optional subscales.The interview is recorded and rated on seven to nine 9-point subscales that tap the various domains of asthma management, with higher scores indicating better management (1 being the worse asthma management and 9 being the best a
Conditions Studied
Interventions
- BEHAVIORAL Project ASPIRE Home-Based Family Intervention
- BEHAVIORAL Project ASPIRE Enhanced Treatment As Usual
Study Locations (2)
Georgia
- Emory University School of Medicine - Atlanta
- American Lung Association - Southeast Division - Smyrna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
What the finished NCT00384813 record still lists
NCT00384813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Project ASPIRE Home-Based Family Intervention is the first listed.
NCT00384813 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00384813 about?
NCT00384813 is a clinical study titled "Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma". Stress and anxiety can negatively affect children with asthma. Reducing the stress of asthmatic children and their families may lead to improved asthma care and fewer asthma symptoms in the children. The purpose of this study is to develop and evaluate a family-focused asthma education program aimed...
What is the current status of trial NCT00384813?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2007-01. Estimated completion is 2009-04.
What conditions does trial NCT00384813 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00384813?
The interventions under investigation include: Project ASPIRE Home-Based Family Intervention (BEHAVIORAL), Project ASPIRE Enhanced Treatment As Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00384813?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00384813 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00384813's enrollment target sits among peer trials
43 277th of 374 higher than 96 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia